Immusoft Alternatives & Competitors
12 companies similar to Immusoft — Cell therapy company dedicated to improving the lives of patients with rare dise...
Companies similar to Immusoft
Affinia Therapeutics
Building the next generation of gene therapies
Sana Biotechnology, Inc.
Focused on creating and delivering engineered cells as medicines for patients
Orchard Therapeutics - U.S.
Dedicated to transforming the lives of patients with severe and other genetic diseases thr...
Edity Therapeutics
Using human immune cells to deliver therapeutic proteins
Rival Readout
Competing with Immusoft? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Mogrify
Transforming the lives of patients with degenerative diseases through a novel class of in...
Eterna Therapeutics
Laser Focus with Relentless Execution
Hopewell Therapeutics, Inc.
Enabling a new generation of genomic medicines for patients with high unmet medical needs.
Senda Biosciences
Harnessing nature to program targeted, potent and tunable medicines
Gennao Bio
A genetic medicines company developing first-in-class, targeted nucleic acid therapeutics
Enlaza Therapeutics
Pioneering Covalent Biologics
Outpace Bio
Revolutionizing Cell Therapy with Protein Design
Alltrna
The world’s first transfer RNA (tRNA) platform company. We are unlocking the vast therapeu...
About Immusoft
Immusoft, a pioneering cell therapy company, is committed to revolutionizing treatments for patients suffering from rare diseases. Utilizing a cutting-edge technology platform known as Immune System Programming (ISP™), Immusoft modifies a patient's B cells to act as miniature drug factories, producing gene-encoded medi...
B Cell Programming, Therapeutic Protein Development, Clinical Research and Development, Biologics Optimization
Patients with Rare Diseases, Biopharmaceutical Companies, Healthcare Providers, Research and Development Organizations
Cell Therapy, Rare Diseases, Therapeutic Proteins, Immune System Programming, B Cell Modification, Gene-Encoded Medicines, Miniature Drug Factories, Sustained Drug Delivery, Gene Editing, Biologics Production, Caltech Licensing, Immune System Reprogramming
B2B, B2C, B2D
Licensing, Performance Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Immusoft: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Immusoft on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.